Citizens Financial Group Inc Sarepta Therapeutics, Inc. Transaction History

Citizens Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$100.86 - $132.13 $2,622 - $3,435	-26 Reduced 0.91%	2,844 $368,000
Q3 2022 Nov 10, 2022	SELL	$75.71 - $119.24 $241,666 - $380,614	-3,192 Reduced 52.66%	2,870 $317,000
Q2 2022 Aug 05, 2022	SELL	$62.69 - $88.44 $178,227 - $251,434	-2,843 Reduced 31.93%	6,062 $454,000
Q1 2022 May 12, 2022	BUY	$63.15 - $90.42 $1,641 - $2,350	26 Added 0.29%	8,905 $696,000
Q3 2021 Nov 05, 2021	BUY	$65.97 - $92.48 $585,747 - $821,129	8,879 New	8,879 $821,000
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $5,084 - $6,893	-40 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $3,720 - $6,868	40 New	40 $6,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.